Login to Your Account

Nice slice of 'mud' pie as Accelerator launches Lodo with $17M series A

By Marie Powers
News Editor

Monday, January 11, 2016

The New York arm of Accelerator Corp. launched its second biopharma in less than a week as Lodo Therapeutics Corp. set out with a $17 million series A financing.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription